期刊文献+

多囊卵巢综合征病因、发病机制及治疗的最新研究进展 被引量:96

Research Progress in the Etiology, Pathogenesis and Treatment of Polycystic Ovary Syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是一种育龄期妇女常见的内分泌紊乱疾病,除了本身固有的多囊样卵巢、高雄激素血症及排卵功能障碍的特征外,常伴有肥胖、2型糖尿病和血脂代谢异常等。随着生活环境的改变,PCOS发病率呈上升趋势。若PCOS病情长期得不到改善,不仅影响患者生殖健康,也影响患者全身健康。虽然对PCOS有了一定的了解,但是PCOS病因复杂、临床表现具有高度异质性,因此更加强调综合治疗。对于有生育需求的PCOS患者,应当在改变生活方式、控制体质量基础上,采用药物诱发排卵解决生育问题;而PCOS促排卵方案的目标是避免多卵泡发育,尽量获得单个卵泡发育;即使在体外受精(IVF)/胞浆内单精子注射(ICSI)中,也应避免过多卵泡发育,防止卵巢过度刺激综合征和多胎妊娠的发生。现就PCOS的病因、发病机制及治疗的研究进展进行综述。 Polycystic ovary syndrome(PCOS)is one of the common endocrine disorders in women of reproductive age.In addition to their inherent polycystic ovary,hyperandrogenism and ovarian dysfunction,there are obesity,type 2 diabetes,dyslipidemia and other metabolic abnormalities.With the change of living environment,the incidence of PCOS gradually increases.If the condition is not improved for a long time,it will not only affect reproductive health,but also affect general health.Although we have made a little progress in understanding PCOS,the complicated etiology and heterogeneous clinical manifestations suggested that the comprehensive treatment was very important for those PCOS women.For those PCOS women with fertility demand,the ovulation induced with drugs will help them to get pregnancy.However,the objective of the ovulation induction should be to get a single developed follicle,and to avoid the multiple developing follicles.In IVF/ICSI cycles,an excess of developing follicles should be avoided so as to prevent ovarian hyperstimulation syndrome(OHSS)and multiple pregnancy.The research progress of the etiology,pathogenesis and treatment of PCOS were briefly discussed in this review.
作者 冷芹 魏兆莲 LENG Qin;WEI Zhao-lian(Reproductive Medicine Center,Department of Obstetrics and Gynecology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)
出处 《国际生殖健康/计划生育杂志》 CAS 2018年第1期57-61,75,共6页 Journal of International Reproductive Health/Family Planning
基金 安徽省自然科学基金项目(1708085MH214)
关键词 多囊卵巢综合征 雄激素类 胰岛素抗药性 高胰岛素血症 二甲双胍 Polycystic ovary syndrome Androgens Insulin resistance Hyperinsulinism Metformin
  • 相关文献

参考文献3

二级参考文献18

  • 1吴效科,Erkkola Risto.胰岛素增敏剂对多囊卵巢综合征患者卵巢局部胰岛素抵抗的影响[J].中华妇产科杂志,2004,39(12):804-808. 被引量:22
  • 2苏庆民,王琦.肥胖人痰湿型体质血脂、血糖、胰岛素及红细胞Na~+—K~+—ATP酶活性的检测[J].中国中医基础医学杂志,1995,1(2):39-41. 被引量:130
  • 3Norman R J, Dewailly D, Legro R S, et al. Polycystic ovary syndrome[J]. Lancet,2007,370(9588) :685 -97.
  • 4Trivax B, Azziz R. Diagnosis of potycystic ovary syndromeClin Obstet Gynecol[ J]. 2007 ,50( 1 ) : 168 - 77.
  • 5Jungheim E S, Lanzendorf S E, Odem R R,et al. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome [ J ]. Fertil Steril, 2009,92( 1 ) :256 -61.
  • 6McCormick B,Thomas M, Maxwell R, et al. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index [ J ]. Fertil Steril, 2008 , 90 (6) :2304 -9.
  • 7Onalan R,Onalan G,Tonguc E,et al. Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization[ J]. Fertil Steril,2009 ,91 (4) :1056 -60.
  • 8Kong W,Wei J,Abidi P.Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins[J].Nat Med,2004,10(12):1344-1347.
  • 9Lee YS,Kim WS,Kim KH,et al.Berberine,a natural plant product,activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J].Diabetes,2006,55(8):2256-2264.
  • 10Rosenfield RL,Barnes RB,Cara JF,et al.Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome[J].Fertil Steril,1990,53(5):785-791.

共引文献227

同被引文献947

引证文献96

二级引证文献443

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部